Skip to main content
Livermore
Livermore
ZHEN

Affinity Asset Advisors, LLC

SEC CIK
0001773195
Latest filing
Aug 13, 2026

BBIO holding history

BridgeBio Pharma, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BBIO overviewAll 13F holders of BBIOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of BBIO by Affinity Asset Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−150,000−100.0%Sold outHolders
Q1 2026150,000$11.1M0.7%−170,000−53.1%ReducedHolders
Q4 2025320,000$24.5M1.8%+255,000+392.3%AddedHolders
Q3 202565,000$3.38M0.3%−85,000−56.7%ReducedHolders
Q2 2025150,000$6.48M1.0%−150,000−50.0%ReducedHolders
Q1 2025300,000$10.4M1.6%+100,000+50.0%AddedHolders
Q4 2024200,000$5.49M0.9%−100,000−33.3%ReducedHolders
Q3 2024300,000$7.64M1.2%+200,000+200.0%AddedHolders
Q2 2024100,000$2.53M0.4%+50,000+100.0%AddedHolders
Q1 202450,000$1.55M0.3%−30,000−37.5%ReducedHolders
Q4 202380,000$3.23M0.6%+50,000+166.7%AddedHolders
Q3 202330,000$791.1K0.3%−5,133−14.6%ReducedHolders
Q2 202335,133$604.3K0.2%−284,867−89.0%ReducedHolders
Q1 2023320,000$5.31M2.0%+320,000NewHolders
Q1 20220$00.0%−494,046−100.0%Sold outHolders
Q4 2021494,046$8.24M3.5%−160,389−24.5%ReducedHolders
Q3 2021654,435$30.7M12.2%+104,435+19.0%AddedHolders
Q2 2021550,000$33.5M16.0%−27,500−4.8%ReducedHolders
Q1 2021577,500$35.6M17.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.